• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH响应性顺铂/利巴韦林负载单分散磁性二氧化硅纳米复合材料对A549肺癌细胞的影响

Impact of pH-Responsive Cisplatin/Ribavirin-Loaded Monodispersed Magnetic Silica Nanocomposite on A549 Lung Cancer Cells.

作者信息

Almohazey Dana, Ravinayagam Vijaya, Dafalla Hatim, Balasamy Rabindran Jermy

机构信息

Department of Stem Cell Research, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.

Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.

出版信息

Pharmaceutics. 2025 May 9;17(5):631. doi: 10.3390/pharmaceutics17050631.

DOI:10.3390/pharmaceutics17050631
PMID:40430922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12115125/
Abstract

: Nanocarrier particle design for treating chronic pulmonary diseases presents several challenges, including anatomical and physiological barriers. Drug-repurposing technology using monodispersed spherical silica is one of the innovative ways to deliver drugs. In the present study, the anticancer potential of combinational cisplatin/ribavirin was explored for targeted lung cancer therapeutics. : Monodispersed spherical silica (80 nm) capable of diffusing into the tracheal mucus region was chosen and doped with 10 wt% superparamagnetic iron oxide nanoparticles (SPIONs). Subsequently, it was wrapped with chitosan (Chi, 0.6 wt/vol%), functionalized with 5% wt/wt cisplatin (Cp)/ribavarin (Rib) and angiotensin-converting enzyme 2 (ACE-2) (1.0 μL/mL). Formulations are based on monodispersed spherical silica or halloysite and are termed as (S/MSSiO/Chi/Cp/Rib) or (S/Hal/Chi/Cp/Rib), respectively. : X-ray diffraction (XRD) and diffuse reflectance UV-visible spectroscopy (DRS-UV-vis) analysis of S/MSSiO/Chi/Cp/Rib confirmed the presence of SPION nanoclusters on the silica surface (45% coverage). The wrapping of chitosan on the silica was confirmed with a Fourier transformed infrared (FTIR) stretching band at 670 cm and ascribed to the amide group of the polymer. The surface charge by zetasizer and saturation magnetization by vibrating sample magnetometer (VSM) were found to be -15.3 mV and 8.4 emu/g. The dialysis membrane technique was used to study the Cp and Rib release between the tumor microenvironment and normal pH ranges from 5.5 to 7.4. S/MSSiO/Chi formulation demonstrated pH-responsive Cp and Rib at acidic pH (5.6) and normal pH (7.4). Cp and Rib showed release of ~27% and ~17% at pH 5.6, which decreases to ~14% and ~3.2% at pH 7.4, respectively. To assess the compatibility and cytotoxic effect of our nanocomposites, the cell viability assay (MTT) was conducted on cancer lung cells A549 and normal HEK293 cells. : The study shows that the designed nanoformulations with multifunctional capabilities are able to diffuse into the lung cells bound with dual drugs and the ACE-2 receptor.

摘要

用于治疗慢性肺部疾病的纳米载体颗粒设计面临诸多挑战,包括解剖学和生理学障碍。使用单分散球形二氧化硅的药物再利用技术是给药的创新方法之一。在本研究中,探索了顺铂/利巴韦林联合用药对肺癌的靶向治疗潜力。:选择能够扩散到气管黏液区域的80纳米单分散球形二氧化硅,并掺杂10重量%的超顺磁性氧化铁纳米颗粒(SPIONs)。随后,用壳聚糖(Chi,0.6重量/体积%)包裹,用5%重量/重量的顺铂(Cp)/利巴韦林(Rib)和血管紧张素转换酶2(ACE-2)(1.0微升/毫升)进行功能化。制剂基于单分散球形二氧化硅或埃洛石,分别称为(S/MSSiO/Chi/Cp/Rib)或(S/Hal/Chi/Cp/Rib)。:对S/MSSiO/Chi/Cp/Rib进行的X射线衍射(XRD)和漫反射紫外-可见光谱(DRS-UV-vis)分析证实了二氧化硅表面存在SPION纳米团簇(覆盖率45%)。壳聚糖在二氧化硅上的包裹通过670厘米处的傅里叶变换红外(FTIR)拉伸带得到证实,归因于聚合物的酰胺基团。通过zeta电位仪测得的表面电荷和通过振动样品磁强计(VSM)测得的饱和磁化强度分别为-15.3毫伏和8.4电磁单位/克。采用透析膜技术研究了肿瘤微环境与pH值在5.5至7.4之间的正常环境中Cp和Rib的释放情况。S/MSSiO/Chi制剂在酸性pH值(5.6)和正常pH值(7.4)下表现出对Cp和Rib的pH响应性。Cp和Rib在pH 5.6时的释放率分别约为27%和约17%,在pH 7.4时分别降至约14%和约3.2%。为了评估我们的纳米复合材料的相容性和细胞毒性作用,对肺癌细胞A549和正常HEK293细胞进行了细胞活力测定(MTT)。:研究表明,所设计的具有多功能能力的纳米制剂能够扩散到与双药和ACE-2受体结合的肺细胞中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/d357c0e3ab2c/pharmaceutics-17-00631-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/c889765581a8/pharmaceutics-17-00631-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/d4c5d44e4534/pharmaceutics-17-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/501fca76d48f/pharmaceutics-17-00631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/a3c197d5a79e/pharmaceutics-17-00631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/fa71c9f3f808/pharmaceutics-17-00631-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/d357c0e3ab2c/pharmaceutics-17-00631-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/c889765581a8/pharmaceutics-17-00631-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/d4c5d44e4534/pharmaceutics-17-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/501fca76d48f/pharmaceutics-17-00631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/a3c197d5a79e/pharmaceutics-17-00631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/fa71c9f3f808/pharmaceutics-17-00631-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac76/12115125/d357c0e3ab2c/pharmaceutics-17-00631-g005.jpg

相似文献

1
Impact of pH-Responsive Cisplatin/Ribavirin-Loaded Monodispersed Magnetic Silica Nanocomposite on A549 Lung Cancer Cells.pH响应性顺铂/利巴韦林负载单分散磁性二氧化硅纳米复合材料对A549肺癌细胞的影响
Pharmaceutics. 2025 May 9;17(5):631. doi: 10.3390/pharmaceutics17050631.
2
SPIONs/3D SiSBA-16 based Multifunctional Nanoformulation for target specific cisplatin release in colon and cervical cancer cell lines.基于 SPIONs/3D SiSBA-16 的多功能纳米制剂,用于结肠癌和宫颈癌细胞系中顺铂的靶向释放。
Sci Rep. 2019 Oct 10;9(1):14523. doi: 10.1038/s41598-019-51051-w.
3
Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFeO/silica/cisplatin nanocomposite formulation.采用CuFeO/二氧化硅/顺铂纳米复合制剂对乳腺癌细胞系MCF-7的靶向治疗效果。
Beilstein J Nanotechnol. 2019 Nov 12;10:2217-2228. doi: 10.3762/bjnano.10.214. eCollection 2019.
4
PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19.聚乙二醇化绿色埃洛石/尖晶石铁氧体纳米复合材料用于地塞米松的pH敏感递送:一种用于COVID-19的潜在肺部药物递送治疗选择。
Appl Clay Sci. 2022 Jan;216:106333. doi: 10.1016/j.clay.2021.106333. Epub 2021 Nov 9.
5
Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.从 PVA/LDH-和 PEG/LDH 包覆的氧化铁纳米粒子中释放肝抗癌药物索拉非尼用于药物输送应用。
Sci Rep. 2020 Dec 9;10(1):21521. doi: 10.1038/s41598-020-76504-5.
6
and Bioimaging Studies of Mesoporous Silica Nanocomposites Encapsulated Iron-oxide and Loaded Doxorubicin Drug (DOX/IO@Silica) as Magnetically Guided Drug Delivery System.介孔硅纳米复合材料封装氧化铁和负载阿霉素药物(DOX/IO@Silica)的磁共振成像和生物成像研究及其作为磁导向药物传递系统。
Curr Pharm Biotechnol. 2023;24(10):1297-1306. doi: 10.2174/1389201023666220428084920.
7
Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.用于药物递送系统的壳聚糖包被磁性纳米颗粒对抗癌剂植酸的持续释放。
Int J Nanomedicine. 2017 Mar 27;12:2361-2372. doi: 10.2147/IJN.S126245. eCollection 2017.
8
Zeolitic Imidazole Framework/Silica Nanocomposite for Targeted Cancer Therapeutics: Comparative Study of Chemo-Drug Cisplatin (CPt) and Green Platinum (GPt) Efficacy.沸石咪唑骨架/二氧化硅纳米复合材料在癌症靶向治疗中的应用:化疗药物顺铂(CPt)和绿色铂(GPt)疗效的对比研究。
Int J Mol Sci. 2024 Mar 9;25(6):3157. doi: 10.3390/ijms25063157.
9
Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.温敏和 pH 值响应性聚合物接枝多功能磁性纳米粒子用于抗癌药物的靶向递送。
ACS Appl Mater Interfaces. 2013 May;5(9):3884-93. doi: 10.1021/am400572b. Epub 2013 Apr 23.
10
Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.聚乙二醇-壳聚糖低聚糖-包覆超顺磁性氧化铁纳米粒子:姜黄素二戊酸的新型药物传递系统。
Biomolecules. 2020 Jan 2;10(1):73. doi: 10.3390/biom10010073.

本文引用的文献

1
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy.用于癌症免疫治疗中精确靶向药物递送和增强治疗效果的工程纳米颗粒。
Acta Pharm Sin B. 2024 Aug;14(8):3432-3456. doi: 10.1016/j.apsb.2024.05.010. Epub 2024 May 13.
2
Impact of SARS-CoV-2 infection on immune cell cuproptosis in patients with lung adenocarcinoma via glutamine regulation.SARS-CoV-2 感染通过调节谷氨酰胺对肺腺癌患者免疫细胞铜死亡的影响。
Int Immunopharmacol. 2024 Oct 25;140:112912. doi: 10.1016/j.intimp.2024.112912. Epub 2024 Aug 10.
3
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.
无症状或未确诊 SARS-CoV-2 感染的肺癌患者特征。
Clin Lung Cancer. 2024 Nov;25(7):612-618. doi: 10.1016/j.cllc.2024.07.007. Epub 2024 Jul 20.
4
Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies.计算机和生物学方法在重新利用利巴韦林治疗肺癌中的应用:揭示抗肿瘤策略。
Life Sci. 2024 Sep 1;352:122859. doi: 10.1016/j.lfs.2024.122859. Epub 2024 Jun 25.
5
Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments.医学纳米技术革新癌症和病毒感染治疗的药物输送方式。
Int J Pharm. 2024 Jul 20;660:124345. doi: 10.1016/j.ijpharm.2024.124345. Epub 2024 Jun 15.
6
Drug repurposing for cancer therapy.药物重用于癌症治疗。
Signal Transduct Target Ther. 2024 Apr 19;9(1):92. doi: 10.1038/s41392-024-01808-1.
7
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
8
Impact of oseltamivir on the risk of cancer.奥司他韦对癌症风险的影响。
Front Oncol. 2024 Feb 26;14:1329986. doi: 10.3389/fonc.2024.1329986. eCollection 2024.
9
JN.1: The Present Public Health Concern Pertains to the Emergence of a Novel Variant of COVID-19.JN.1:当前的公共卫生关注点与新冠病毒一种新变种的出现有关。
Environ Health Insights. 2024 Feb 1;18:11786302241228958. doi: 10.1177/11786302241228958. eCollection 2024.
10
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition.抗病毒药物法匹拉韦与他莫昔芬联合通过抑制端粒酶逆转录酶(hTERT)在他莫昔芬耐药乳腺癌细胞中发挥协同作用。
Sci Rep. 2024 Jan 22;14(1):1844. doi: 10.1038/s41598-024-51977-w.